// App-Quantinova.ai

e12522 : Incidence of long-term hair loss (LHL) following docetaxel (D)-containing non-anthracycline (A) adjuvant chemotherapy (Adj) of early stage breast cancer (ESB).

Researchers

Presenter

  • John Crown

Principal Investigators

  • Janice Maria Walshe

  • David William Fennelly

  • Jessica-Clare Long

  • Josephine Ballot

  • Deirdre McDonnell

  • Susan Cairney

  • Therese Lyons

  • Aileen O'Meara

  • Conor Buckley

  • John Gannon

  • Mary Quinn

  • Giuseppe Gullo

Medical Centers

  • NSABP/NRG Oncology, and The IIrish Cooperative Oncology Research Group, Dublin, Ireland

  • ICORG, Dublin, Ireland

  • St Vincent's University Hospital, Dublin, Ireland

  • Medical Oncology Research Office, Dublin, Ireland

  • St Vincent's University Hospital, Dublin, Ireland

  • Saint Vincent's Private Hospital, Dublin, Ireland

  • St Vincent's University Hospital, Dublin, Ireland

Locations

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved